Rani Therapeutics Holdings, Inc.
NASDAQ:RANI
2.37 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Rani Therapeutics Holdings, Inc. |
Symbool | RANI |
Munteenheid | USD |
Prijs | 2.37 |
Beurswaarde | 126,572,372 |
Dividendpercentage | 0% |
52-weken bereik | 1.82 - 8.75 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Talat Imran |
Website | https://www.ranitherapeutics.com |
An error occurred while fetching data.
Over Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)